Metethoheptazine

Metethoheptazine[1] (WY-535) is an opioid analgesic from the phenazepine family. It was invented in the 1960s.[2]

Metethoheptazine

Clinical data
Other names	WY-535
ATC code	none
Identifiers
IUPAC name ethyl 1,3-dimethyl-4-phenylazepane-4-carboxylate
CAS Number	509-84-2^N
PubChem CID	176888
ChemSpider	154060^Y
UNII	S36J5ZY2TH
Chemical and physical data
Formula	C17H25NO2
Molar mass	275.392 g·mol^−1
3D model (JSmol)	Interactive image
SMILES O=C(OCC)C2(c1ccccc1)CCCN(C)CC2C
InChI InChI=1S/C17H25NO2/c1-4-20-16(19)17(15-9-6-5-7-10-15)11-8-12-18(3)13-14(17)2/h5-7,9-10,14H,4,8,11-13H2,1-3H3^Y Key:BOSULDNQDJLKKL-UHFFFAOYSA-N^Y
^NY (what is this?)  (verify)

Metethoheptazine produces similar effects to other opioids, including analgesia, sedation, dizziness and nausea.

Metethoheptazine is not listed as a controlled substance under the Controlled Substances Act 1970 in the United States.[3] The Canadian Controlled Drugs and Substances Act specifically excludes the phenazepine opioids from control.

References

1. GB Patent 843924
2. Walkenstein SS, Corradino RA, Wiser R, Gudmundsen CH. Metabolism of the Non-Narcotic Analgesic, WY-535. Biochemical Pharmacology. 1965 Feb;14:121-8.
3. "Conversion Factors for Controlled Substances". U.S. Department of Justice Drug Enforcement Administration. Retrieved 8 October 2018.